Patent · US Expired

Antibody with specificity for colon cancer

US7425623B2 · kind B2 · utility

1Cited by

1References

13Claims

0Family size

Assignee

Active Biotech AB · SE

Inventors

Thomas Brodin · Ayacucho, PE
Pia J. Karlström · Lund, SE
Lennart Ohlsson · Lund, SE
Jesper Tordsson · Lund, SE
Bo Nilson · Lund, SE

Key dates

Filing date	Feb 23, 2001
Grant date	Sep 16, 2008
Priority date	—
Expiry date	Nov 11, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A binding structure which binds in, and/or to the surface of, tumour cells; a target structure displayed and/or expressed in, or on the surface of, tumour cells; a binding structure that recognises and blocks said target structure; a substance that binds to or blocks the expression of said target structure; pharmaceutical compositions comprising said binding structure, target structures or substance as active principles; vaccine compositions comprising said target structures as active principles; a method for phage selection; and methods of in vitro and in vivo diagnosis and prognosis, and of treatment of human malignant diseases comprising the use of the above subject matters, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.